Veru (VERU) Interest Coverage Ratio: History & Chart

Veru Inc.(VERU)

Biotechnology · Miami, FL

$2.50-0.05 (-1.96%)

Delayed quote: Oct 6, 2026, 3:25 PM EDT

About Veru Inc.

Veru Inc. operates as a biopharmaceutical firm primarily dedicated to advancing novel therapeutic agents for various types of cancer. Commercially, Veru markets the FC2 internal condom, designed to offer dual protection against both unplanned pregnancies and the transmission of sexually transmitted infections. This product is distributed globally to a diverse clientele, including governmental health departments, UN organizations, non-profit entities, and commercial distributors. Its robust development pipeline features a range of investigational therapies, notably within oncology: Enobosarm, an orally administered selective androgen receptor agonist, is progressing through Phase III clinical trials for treating metastatic breast cancer that is AR+, ER+, and HER2-negative. Sabizabulin is undergoing Phase IIb studies for the same type of metastatic breast cancer. Furthermore, a combination therapy of Enobosarm with abemaciclib is in Phase III for AR+ ER+ HER2- metastatic breast cancer. For metastatic triple-negative breast cancer, Veru is exploring a combination of Sabizabulin (an oral targeted cytoskeleton disruptor) and Enobosarm (a selective androgen receptor agonist) in Phase II trials. The company's portfolio also extends to prostate cancer: Sabizabulin is in Phase II trials for metastatic castration and androgen receptor targeting agent-resistant prostate cancer. VERU-100, a GnRH antagonist peptide delivered via injection, is also in Phase II for advanced hormone-sensitive prostate cancer. Beyond oncology, Veru is investigating other conditions: Zuclomiphene Citrate is in Phase II for managing hot flashes. Sabizabulin has reached Phase III for treating SARS-CoV-2 in high-risk patients susceptible to acute respiratory distress syndrome. Additionally, the firm is developing a novel pharmaceutical formulation aimed at alleviating lower urinary tract symptoms associated with an enlarged prostate in men. Originally established as The Female Health Company in 1971, the corporation adopted the name Veru Inc. in July 2017. Its corporate headquarters are situated in Miami, Florida.

Miami, FL

20 employees

www.verupharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Mitchell S. Steiner

View full financials

VERU Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-48.30x

INTEREST COVERAGE RATIO AVG TTM

-58.42x

INTEREST COVERAGE RATIO AVG 3Y

-37.34x

INTEREST COVERAGE RATIO AVG 5Y

-23.18x

INTEREST COVERAGE RATIO AVG 10Y

-19.48x

INTEREST COVERAGE RATIO AVG 15Y

-2.39x

INTEREST COVERAGE RATIO AVG 20Y

-2.03x

CURRENT VS TTM AVG

+17.32%

CURRENT VS 3Y AVG

-29.35%

CURRENT VS 5Y AVG

-108.39%

CURRENT VS 10Y AVG

-147.98%

CURRENT VS 15Y AVG

-1917.55%

CURRENT VS 20Y AVG

-2278.96%

SECTOR MEDIAN · HEALTHCARE

-6.38x

median of 528 covered companies

CURRENT VS SECTOR MEDIAN

-657.71%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Veru Inc. (VERU)	$40.13M	-48.30x	-58.42x	-37.34x	-23.18x
Filana Therapeutics, Inc. (FLNA)vs ›	$40.70M	N/A	N/A	N/A	N/A
Metagenomi, Inc. Common Stock (MGX)vs ›	$38.96M	N/A	N/A	N/A	N/A
Harvard Bioscience, Inc. (HBIO)vs ›	$38.52M	-0.13x	0.53x	0.64x	0.43x
Nephros, Inc. (NEPH)vs ›	$38.00M	1146.00x	576.00x	576.00x	576.00x
Precipio, Inc. (PRPO)vs ›	$41.95M	-16.47x	N/A	N/A	N/A
Incannex Healthcare Limited (IXHL)vs ›	$37.70M	N/A	N/A	N/A	N/A
BioStem Technologies, Inc. (BSEM)vs ›	$42.46M	N/A	53.13x	53.13x	53.13x
QT Imaging Holdings, Inc. (QTI)vs ›	$36.42M	-1.68x	N/A	N/A	N/A
Nano-X Imaging Ltd. (NNOX)vs ›	$42.80M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Veru Inc. (VERU)

$40.13M

-48.30x

-58.42x

-37.34x

-23.18x

Filana Therapeutics, Inc. (FLNA)vs ›

$40.70M

N/A

Metagenomi, Inc. Common Stock (MGX)vs ›

$38.96M

N/A

Harvard Bioscience, Inc. (HBIO)vs ›

$38.52M

-0.13x

0.53x

0.64x

0.43x

Nephros, Inc. (NEPH)vs ›

$38.00M

1146.00x

576.00x

Precipio, Inc. (PRPO)vs ›

$41.95M

-16.47x

N/A

Incannex Healthcare Limited (IXHL)vs ›

$37.70M

N/A

BioStem Technologies, Inc. (BSEM)vs ›

$42.46M

N/A

53.13x

QT Imaging Holdings, Inc. (QTI)vs ›

$36.42M

-1.68x

N/A

Nano-X Imaging Ltd. (NNOX)vs ›

$42.80M

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Veru Inc. (VERU)?

The interest coverage ratio for VERU stock is -48.30x.

Is Veru Inc.'s interest coverage ratio high or low?

The interest coverage ratio of -48.30x is 108% below its 5-year average of -23.18x, around the middle of its 5-year range (-85.90x–16.32x).

What is the TTM average interest coverage ratio for Veru Inc. (VERU)?

The TTM average interest coverage ratio for VERU stock is -58.42x.

What is the 3Y average interest coverage ratio for Veru Inc. (VERU)?

The 3Y average interest coverage ratio for VERU stock is -37.34x.

What is the 5Y average interest coverage ratio for Veru Inc. (VERU)?

The 5Y average interest coverage ratio for VERU stock is -23.18x.

What is the 10Y average interest coverage ratio for Veru Inc. (VERU)?

The 10Y average interest coverage ratio for VERU stock is -19.48x.

What is the 15Y average interest coverage ratio for Veru Inc. (VERU)?

The 15Y average interest coverage ratio for VERU stock is -2.39x.

What is the 20Y average interest coverage ratio for Veru Inc. (VERU)?

The 20Y average interest coverage ratio for VERU stock is -2.03x.

DATE	INTEREST COVERAGE RATIO
2024-09-30	-48.30x
2024-06-30	-85.90x
2024-03-31	-68.05x
2023-12-31	-50.38x
2023-09-30	-39.46x
2023-06-30	-12.13x
2023-03-31	-49.33x
2022-12-31	-42.89x
2022-09-30	-54.99x
2022-06-30	-18.42x
2022-03-31	-9.70x
2021-12-31	-4.28x
2021-09-30	-1.62x
2021-06-30	-2.23x
2021-03-31	-1.18x
2020-12-31	16.32x
2020-09-30	-9.84x
2020-06-30	-1.21x
2020-03-31	-0.26x
2019-12-31	-1.56x
2019-09-30	-1.35x
2019-06-30	-1.69x
2019-03-31	-1.69x
2018-12-31	-0.79x
2018-09-30	-3.09x
2018-06-30	-3.60x
2018-03-31	-13.40x
2017-12-31	-61.93x
2017-09-30	-1.44x
2017-06-30	-23.62x
2017-03-31	-85.41x
2016-12-31	-55.96x
2016-09-30	-0.10x
2016-06-30	9.79x
2016-03-31	0.66x
2015-12-31	20.33x
2015-06-30	749.02x
2015-03-31	767.87x
2014-09-30	-12.02x
2014-06-30	62.14x
2013-12-31	41.04x
2013-09-30	53.35x
2013-06-30	16.19x
2012-12-31	45.71x
2012-09-30	20.10x
2012-03-31	33.70x
2011-12-31	26.70x
2011-06-30	12.31x
2011-03-31	1.88x
2010-12-31	7.10x
2010-09-30	86.56x
2010-03-31	377.61x
2009-12-31	-0.17x
2009-09-30	0.21x
2009-06-30	3265.25x
2009-03-31	5.78x
2008-12-31	49.38x
2008-06-30	6.67x
2008-03-31	271.28x
2004-12-31	-0.02x
2004-03-31	0.00x
2003-12-31	0.00x

DATE

INTEREST COVERAGE RATIO

2024-09-30

-48.30x

2024-06-30

-85.90x

2024-03-31

-68.05x

2023-12-31

-50.38x

2023-09-30

-39.46x

2023-06-30

-12.13x

2023-03-31

-49.33x

2022-12-31

-42.89x

2022-09-30

-54.99x

2022-06-30

-18.42x

2022-03-31

-9.70x

2021-12-31

-4.28x

2021-09-30

-1.62x

2021-06-30

-2.23x

2021-03-31

-1.18x

2020-12-31

16.32x

2020-09-30

-9.84x

2020-06-30

-1.21x

2020-03-31

-0.26x

2019-12-31

-1.56x

2019-09-30

-1.35x

2019-06-30

-1.69x

2019-03-31

-1.69x

2018-12-31

-0.79x

2018-09-30

-3.09x

2018-06-30

-3.60x

2018-03-31

-13.40x

2017-12-31

-61.93x

2017-09-30

-1.44x

2017-06-30

-23.62x

2017-03-31

-85.41x

2016-12-31

-55.96x

2016-09-30

-0.10x

2016-06-30

9.79x

2016-03-31

0.66x

2015-12-31

20.33x

2015-06-30

749.02x

2015-03-31

767.87x

2014-09-30

-12.02x

2014-06-30

62.14x

2013-12-31

41.04x

2013-09-30

53.35x

2013-06-30

16.19x

2012-12-31

45.71x

2012-09-30

20.10x

2012-03-31

33.70x

2011-12-31

26.70x

2011-06-30

12.31x

2011-03-31

1.88x

2010-12-31

7.10x

2010-09-30

86.56x

2010-03-31

377.61x

2009-12-31

-0.17x

2009-09-30

0.21x

2009-06-30

3265.25x

2009-03-31

5.78x

2008-12-31

49.38x

2008-06-30

6.67x

2008-03-31

271.28x

2004-12-31

-0.02x

2004-03-31

0.00x

2003-12-31

0.00x

Interest Coverage Ratio: -48.30x

VERU Interest Coverage Ratio

VERU Average Interest Coverage Ratio Chart

VERU Current vs Average Interest Coverage Ratio Chart

VERU Interest Coverage Ratio Metrics

VERU Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

VERU Interest Coverage Ratio History

Related Metrics